Considering the high frequency of mutated APC in patients with colorectal cancer, further studies are needed to investigate APC’s molecular mechanism in β-catenin degradation, its use as a potential biomarker and other possible therapeutic targeting approaches. Here, APC is linked to colorectal cancer.